Virios Therapeutics (VIRI) Reports Q4 Loss of $1.25/sh

Virios Therapeutics (NASDAQ: VIRI) reported Q4 EPS of ($1.25), versus ($0.13) reported last year.

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Can global equities keep rising? UBS sees these factors driving upside
• Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold